Improving Post-PCI Outcomes: Part 2 of 4

Assessing Coronary Vascular Risk Associated with Bare Metal and Drug-Eluting Stents

Activity Expiration

Please note: This activity has expired.

Technical Requirements:
A broadband internet connection
Operating system: Microsoft Windows 98 or later; Mac OS X
Web browser: Microsoft Internet Explorer 6.0 or later; Mozilla Firefox 1.5 or later; Apple Safari
Adobe Flash Player 9.0 or later
(Available at: Get.adobe.com/flashplayer/)

This is a 4-Part Series:
Click here for Part 1.
Click here for Part 3.
Click here for Part 4.

Statement of Need:
Evidence suggests that the greatest barrier to long-term risk-reduction following an acute coronary event is patient adherence. Data from the American Heart Association suggests that 18% of men and 23% of women over the age of 40 will die within 1 year of an initial myocardial infarction. Meanwhile, approximately 20% of acute coronary syndrome (ACS) patients are rehospitalized within 1 year. However, the evidence-based therapeutic management of ACS remains suboptimal.

Target Audience:
This activity has been designed to meet the educational needs of physicians and other clinicians who treat and manage patients following an acute coronary event.

Learning Objective:
Review available treatment approaches for the management of patients with acute coronary syndromes and select appropriate treatments for improving survivorship

Faculty:
Sarah A. Spinler, PharmD, FCCP, BCPS (AQ Cardiology) Activity Chair Professor of Clinical Pharmacy
Department of Pharmacy Practice and Pharmacy Administration
University of the Sciences in Philadelphia
Philadelphia College of Pharmacy
Philadelphia, Pennsylvania

CME Reviewer:
Gordon F. West, PhD
Annenberg Center for Health Sciences at Eisenhower
Rancho Mirage, CA

This activity will address professional practice gaps in knowledge and competence.

Accreditation and Credit Designation Statement:
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Annenberg Center for Health Sciences at Eisenhower and Independent Medical Education, LLC (IME). The Annenberg Center is accredited by the ACCME to provide continuing medical education for physicians.

The Annenberg Center designates this educational activity for a maximum of .25 AMA PRA Category 1 Credit